Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jounce Therapeutics, Inc. - Common Stock (NQ: JNCE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jounce Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Jounce Therapeutics, Inc. (Nasdaq- JNCE) and Berkshire Grey, Inc. (Nasdaq- BGRY)
From Brodsky & Smith LLC
Via GlobeNewswire
Nasdaq Edges Lower; Unity Biotechnology Shares Plummet
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.91% to 32,530.40 while the NASDAQ fell 0.09% to 11,813.90. The S&P 500, also... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. 
Via Benzinga
Gold Drops Over 1%; First Citizens BancShares Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 32,372.55 while the NASDAQ rose 0.01% to 11,825.46. The S&P 500, also... 
Via Benzinga
JNCE STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Jounce Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Top 5 Health Care Stocks That May Crash In March
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Investors are on the hunt for undervalued, underfollowed and emerging stocks when it comes to spotting opportunities. Retail traders have countless methods at their disposal to uncover new... 
Via Benzinga
Why Jounce Therapeutics Shares Are Trading Higher Today
Via Benzinga
Jounce Therapeutics Says JTX-8064/Pimivalimab Shows Deep, Durable Responses In Pretreated Ovarian Cancer Patients
  
Via Benzinga
S&P 500 Down Over 1%; ThermoGenesis Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 400 points on Wednesday. The Dow traded down 1.32% to 31,732.39 while the NASDAQ fell 0.24% to 11,400.70. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Down Over 100 Points; Crude Oil Drops 5%
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Wednesday. The Dow traded down 1.52% to 31,665.62 while the NASDAQ fell 1% to 11,314.36. The... 
Via Benzinga
Why Is Boxed (BOXD) Stock Down 41% Today?
Boxed (BOXD) stock is falling hard on Wednesday after the company floated the possibility of a bankruptcy filing to investors. 
Via InvestorPlace
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is Inpixon (INPX) Stock Down 34% Today?
Inpixon (INPX) stock is falling on Wednesday after the company announced the merger of subsidiary CXApp with KINS Technology Group. 
Via InvestorPlace
Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Why Is Jounce Therapeutics (JNCE) Stock Up 37% Today?
Jounce Therapeutics (JNCE) stock is climbing higher on Wednesday after getting an unexpected acquisition bid from Concentra Biosciences. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
JOUNCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Jounce Therapeutics, Inc. - JNCE
From Kahn Swick & Foti, LLC
Via Business Wire
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
Via Benzinga
Why Is Cyren (CYRN) Stock Down 27% Today?
Cyren (CYRN) stock is dropping on Thursday as the cybersecurity company deals with recent headwinds from its liquidation plans. 
Via InvestorPlace
Why Is Lucira Health (LHDX) Stock Down 34% Today?
Lucira Health (LHDX) stock is taking a beating today after the company filed for Chapter 11 bankruptcy protection. 
Via InvestorPlace
Why Is Intuitive Machines (LUNR) Stock Up 15% Today?
Intuitive Machines (LUNR) stock continues to be a hot topic among traders on Thursday as a recent rally pushes it even higher! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.